EUCTR2005-001248-22-SE进行中（未招募）不适用
A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone.
Fertilitetsklinikken Herlev Hospital0 个研究点目标入组 2,686 人开始时间: 2005年9月27日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,686
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women 18 to 40 years who are undergoing IVF/ICSI treatment and are willing to sign Informed Consent form.
- •Regular menstrual cycles 25 to 35 days.
- •Both ovaries present.
- •No more than 2 previous IVF attempts.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •More than 2 previous IVF attempts.
- •Known drug abuse.
- •Known allergies to the study medication.
- •No embryo transfer performed in the study cycle.
- •Previous participation in the study.
研究者
相似试验
进行中（未招募）
1 期
A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone.EUCTR2005-001248-22-DKFertilitetsklinikken Nordica2,686
招募中
2 期
A multicenter, prospective randomized study to compare vascular healing after deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) versus the Everolimus Eluting Stent in patients with Acute Coronary Syndrome by means of Optical Coherence TomographyHeart attack10011082Acute Coronary SyndromeNL-OMON36157OrbusNeich Medical B.V.20
招募中
不适用
Comparison of IVF-ET outcomes with GnRH antagonist started either on stimulation day 1 and 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndromeEndocrine, nutritional and metabolic diseaseKCT0000157Seoul National University Hospital267
招募中
4 期
Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures in women with a clinical vertebral fracture or recent hip fracture (imminent risk of fracture) caused by bone fragility.2025-521301-40-00Gedeon Richter Iberica S.A.127
已完成
4 期
*A prospective randomized multicenter study to demonstrate the superiority of the Barricaid® to discectomy for primary lumbar disc herniation*: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and Interaction with Other Risk Factors100432371004154310009720sciaticalumbar disc herniationNL-OMON55882Intrinsic Therapeutics, GmbH66